Mirae Asset Capital Life Science
Venture Capital
U.S. affiliate of Mirae Asset Financial Group investing in private biotechs focused on oncology, neuroscience, metabolic disease, and eye disorders.
2+ investments · 2 portfolio companies
Biotech
- Website
- lifesci.miraeasset.com
- AUM
- $50.0M
- Portfolio Companies
- 2
- Total Investments
- 2
- Last Investment
- Jan 2026
- Geographic Focus
- United States
Investment Thesis
Backs private biotechs developing novel therapeutics in oncology, immunology, cardiovascular and cardiometabolic disease, planning to support up to eight portfolio companies from its $50M debut fund.
Mirae Asset Capital Life Science is a Venture Capital firm. It has made 2 investments in Biotech, including Precede Biosciences and Attovia.
Portfolio2
Co-investors13
Sign up to view co-investors
13 co-investors across 14 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×10 · Corporate VC ×2 · Private Equity ×1 · 7 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/mirae-asset-capital-life-science"><img src="https://indexed.vc/api/badge/investor/mirae-asset-capital-life-science" alt="Mirae Asset Capital Life Science on Indexed.vc" width="260" height="76" /></a>